| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/18/2013 | WO2013053158A1 Compositions and methods for treating heart failure |
| 04/18/2013 | WO2013053080A1 Anti-tumour fusion protein and coding gene and use thereof |
| 04/18/2013 | WO2013053076A1 Compositions and methods for treating heart failure |
| 04/18/2013 | WO2013053050A1 Tubulin-interacting protein, caltubin, promotes axonal growth |
| 04/18/2013 | WO2013028070A3 Compounds for use in boosting coagulation |
| 04/18/2013 | WO2013026913A3 Protein comprising nc-1 for treating angiogenesis-related diseases |
| 04/18/2013 | WO2013023043A3 Treatment of advanced solid tumors using combination of anti-erbb3 immunotherapy and selected chemotherapy |
| 04/18/2013 | WO2013022991A3 Methods and compositions relating to p62 for the treatment and prophylaxis of cancer |
| 04/18/2013 | WO2013020079A3 Conjugates of an il-11 moiety and a polymer |
| 04/18/2013 | WO2013002531A3 Pharmaceutical composition for treating scars on the skin, and method for treating scars on the skin using same |
| 04/18/2013 | US20130097717 Compositions and methods for re-programming cells without genetic modification for treatment of cardiovascular diseases |
| 04/18/2013 | US20130096180 Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same |
| 04/18/2013 | US20130096176 Modulation of insulin like growth factor i receptor expression |
| 04/18/2013 | US20130096137 Treating Sexual Desire Disorders with Flibanserin |
| 04/18/2013 | US20130096074 Protein hydrolysate enriched in peptides inhibiting dpp-iv and their use |
| 04/18/2013 | US20130096073 Casein Derived Peptides And Uses Thereof |
| 04/18/2013 | US20130096072 Zymogen Activators |
| 04/18/2013 | US20130096070 Peptide targeting of inner ear cells |
| 04/18/2013 | US20130096069 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 04/18/2013 | US20130096066 Pharmaceutical formulation for reducing pain |
| 04/18/2013 | US20130096064 Flowable formulations for tissue repair and regeneration |
| 04/18/2013 | US20130096063 Hemostatic compositions |
| 04/18/2013 | US20130096062 Hemostatic compositions |
| 04/18/2013 | US20130096061 Method of treating skeletal dysplasias using vessel dilator |
| 04/18/2013 | US20130096060 Glp-1 agonist for use in the treatment of stenosis or/and obstruction in the pancreatic duct system |
| 04/18/2013 | US20130096059 Glp-1 agonist for use in the treatment of stenosis or/and obstruction in the biliary tract |
| 04/18/2013 | US20130096056 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| 04/18/2013 | US20130096054 Latent human immunodeficiency virus reactiviation |
| 04/18/2013 | US20130096050 Highly active polypeptides and methods of making and using the same |
| 04/18/2013 | US20130096048 Treatment of sepsis and septic shock using ghrelin and growth hormone |
| 04/18/2013 | US20130095569 Pregnancy-associated plasma protein-a2 (papp-a2) polynucleotides |
| 04/18/2013 | US20130095549 Tweak receptor |
| 04/18/2013 | US20130095482 Methods of detecting pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/18/2013 | US20130095229 Method of forming dextran and thrombin sheets |
| 04/18/2013 | US20130095189 Composition and method of phytonutrients for metabolic programming effects |
| 04/18/2013 | US20130095186 Temperature-sensitive carrier for carrying a physiologically active substance and preparation method thereof |
| 04/18/2013 | US20130095184 Metal-Containing Materials for Treatment of Bacterial Conditions |
| 04/18/2013 | US20130095175 Treating neurological disorders |
| 04/18/2013 | US20130095165 Stabilizers for hemostatic products |
| 04/18/2013 | US20130095152 Methods and compositions for the treatment of symptoms of complex regional pain syndrome |
| 04/18/2013 | US20130095127 METHODS OF INHIBITING INFLAMMATION AND INFLAMMATORY DISEASES USING Gal-3BP (BTBD17B, LGALS3BP, GALECTIN-3 BINDING PROTEIN, MAC-2 BINDING PROTEIN) |
| 04/18/2013 | US20130095125 Palatinose for enhancing dietary supplement and pharmaceutical delivery |
| 04/18/2013 | US20130095108 Factor xii inhibitors for treating interstitial lung disease |
| 04/18/2013 | US20130095105 Treatment of Ocular Disease |
| 04/18/2013 | US20130095095 Method for treating thrombotic disorders using quercetin-containing compositions |
| 04/18/2013 | US20130095092 Recombinant human naglu protein and uses thereof |
| 04/18/2013 | US20130095091 Methods of regulating uptake and transcellular transport of leukocytes and therapeutics |
| 04/18/2013 | US20130095089 Glucosylceramide synthase inhibitors and therapeutic methods using the same |
| 04/18/2013 | US20130095087 Absorbable in situ gel-forming system, method of making and use thereof |
| 04/18/2013 | US20130095082 Use of des-aspartate-angiotensin i in inflammation-related pathologies and diseases |
| 04/18/2013 | US20130095081 Compositions and methods of treatment with stem cells |
| 04/18/2013 | US20130095078 Methods for regenerating skeletal muscle |
| 04/18/2013 | US20130095075 Bone morphogenic protein binding peptide |
| 04/18/2013 | US20130095074 Use of caftaric acid and lactic bacterium in food supplement for regulating skin pigmentation |
| 04/18/2013 | US20130095069 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist |
| 04/18/2013 | US20130095068 Agent for treating hcv infection |
| 04/18/2013 | US20130095067 Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae |
| 04/18/2013 | US20130095064 Substituted 3',5'-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections |
| 04/18/2013 | US20130095063 Compounds for the Treatment of Hepatitis C |
| 04/18/2013 | US20130095062 Recombinant production of authentic human proteins using human cell expression systems |
| 04/18/2013 | US20130095060 Pharmaceutical composition for promoting arteriogenesis, and preparation method and applications for the same |
| 04/18/2013 | US20130095057 Compounds for the treatment of clostridium difficile-associated disease |
| 04/18/2013 | US20130095053 Regulation of skin pigmentation by neuregulin-1 (nrg-1) |
| 04/18/2013 | US20130095034 Anti-CD74 Immunoconjugates and Methods |
| 04/18/2013 | US20130095032 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 04/18/2013 | DE19714913B4 Verfahren zur Herstellung patientenspezifischer Immunadsorber Process for the preparation of patient-specific immuno |
| 04/18/2013 | DE102004004043B4 Reinigung von hochmolekularen Verbindungen mittels Affinitätsmembranchromatographie Purification of high molecular weight compounds by means of affinity membrane chromatography |
| 04/18/2013 | CA2852107A1 Partially hydrolyzed casein-whey nutritional compositions for reducing the onset of allergies |
| 04/18/2013 | CA2852064A1 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof |
| 04/18/2013 | CA2852027A1 Recombinant human naglu protein and uses thereof |
| 04/18/2013 | CA2851844A1 Compositions and methods for modulating thrombin generation |
| 04/18/2013 | CA2851761A1 Method of diagnosis, prognostic or treatment of neurodegenerative diseases |
| 04/18/2013 | CA2851667A1 Cd40l-specific tn3-derived scaffolds and methods of use thereof |
| 04/18/2013 | CA2851643A1 Topical formulations of chemerin c15 peptides for the treatment of dermatological conditions |
| 04/18/2013 | CA2851371A1 Zymogen activators |
| 04/18/2013 | CA2851284A1 Treatment of breast cancer with companion diagnostic |
| 04/18/2013 | CA2851131A1 Ophthalmic composition containing cyclosporin and method for preparing same |
| 04/18/2013 | CA2850575A1 Combination medicament comprising il-12 and an agent for blockade of t-cell inhibitory molecules for tumour therapy |
| 04/18/2013 | CA2850560A1 Compositions and methods for treating heart failure |
| 04/18/2013 | CA2850514A1 Peptide inhibitors of bace1 |
| 04/18/2013 | CA2846598A1 Treatment of degenerative joint disease |
| 04/17/2013 | EP2581450A2 Non-natural amino acid substituted polypeptides |
| 04/17/2013 | EP2581445A1 Regulators of MMP-9 and uses thereof |
| 04/17/2013 | EP2581441A1 Method of treating autoimmune disease with mesenchymal stem cells |
| 04/17/2013 | EP2581389A1 Fusion protein of exendin-4 and its analog, preparation method and use thereof |
| 04/17/2013 | EP2581380A1 Sialic acid ( -(2 6)-d-aminopyranose derivatives, synthesis methods and uses thereof |
| 04/17/2013 | EP2580248A1 An enzymatic method of producing a hydrogel from xylan |
| 04/17/2013 | EP2580242A1 Modulation of the interaction between sorla and gdnf-family ligand receptors |
| 04/17/2013 | EP2580237A1 Novel peptides for wound healing |
| 04/17/2013 | EP2580235A1 Antimicrobial peptide variants and polynucleotides encoding same |
| 04/17/2013 | EP2580234A1 Methods and systems for adenovirus interaction with desmoglein 2 (dsg2) |
| 04/17/2013 | EP2580233A1 Materials and method for suppressing inflamatory and neuropathic pain |
| 04/17/2013 | EP2580231A1 Peptides, constructs and uses therefor |
| 04/17/2013 | EP2579945A2 Inhibiting striated muscle activator of rho signaling (stars) to improve glycemic control |
| 04/17/2013 | EP2579893A2 Multivalent glycopeptide constructs and uses thereof |
| 04/17/2013 | EP2579891A2 Methods of mitigating effects of radiation and reducing the risk of systemic infection |
| 04/17/2013 | EP2579890A1 Treatment of coagulopathy with hyperfibrinolysis |
| 04/17/2013 | EP2579889A2 Fgf21 analogues and derivatives |
| 04/17/2013 | EP2579888A2 Novel glp-1 receptor stabilizers and modulators |
| 04/17/2013 | EP2579887A1 Novel auristatin derivatives and use thereof |